跳到正文

太平洋生物科学公司的争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 1 条

  1. 2019

    PGI 对 PacBio 提起专利侵权诉讼

    提起诉讼

    Personal Genomics Taiwan, Inc.(PGI)在美国地区法院对 Pacific Biosciences of California, Inc.(PacBio)提起诉讼。诉状指控 PacBio 的 Sequel 和 Sequel II 产品及相关商业化活动侵犯其美国专利第 7,767,441 号的权利要求。该诉讼被记录为两家公司之间的专利侵权纠纷。

    来源摘录

    • Personal Genomics Taiwan, Inc. ("PGI"), today announced that it has filed a complaint in the U.S. District Court for the District of Delaware against Pacific Biosciences of California, Inc. ("PacBio"). The complaint asserts that PacBio's Sequel and Sequel II, as well as related commercialization activities by PacBio, infringe one or more claims of U.S. Patent No. 7,767,441 (the "'441 patent"), owned by PGI.